Epidermolysis Bullosa Latest Advances
Find the Latest Research About Epidermolysis Bullosa
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6772 publications
Epidermolysis bullosa and global challenges in translational research for rare diseases.
Journal: Einstein (Sao Paulo, Brazil)
Published: April 15, 2026
Successful Treatment of Dystrophic Epidermolysis Bullosa With the JAK1 Inhibitor Abrocitinib.
Journal: Journal of drugs in dermatology : JDD
Published: April 03, 2026
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
L-Carnitine in Dermatology: A Systematic Review of Therapeutic Potential and Biomarker Applications.
Journal: Journal of cutaneous medicine and surgery
Published: March 25, 2026
The role of antibody class and target on subepidermal blistering disease phenotype and management.
Journal: Italian journal of dermatology and venereology
Published: March 16, 2026
A Novel Nasal Continuous Positive Airway Pressure-Assisted Approach for Airway Management in a Patient With Dystrophic Epidermolysis Bullosa: A Case Report.
Journal: Cureus
Published: March 14, 2026
Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa.
Journal: Expert review of clinical pharmacology
Published: March 03, 2026
An evaluation of prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis bullosa.
Journal: Expert opinion on biological therapy
Published: March 01, 2026
Dupilumab Use in Severe Epidermolysis Bullosa Simplex.
Journal: JAMA dermatology
Published: February 25, 2026
Topical Gentamicin in the Management of Bart Syndrome: A Case Report.
Journal: Cureus
Published: February 23, 2026
Innovative Impression Technique for Microstomia Induced by Epidermolysis Bullosa.
Journal: Cureus
Published: February 17, 2026
Last Updated: 04/28/2026